Before you compare accuracy specs or sensor wear time, there is a more basic question worth answering first: can you actually get a prescription CGM covered, or are you about to spend weeks fighting an insurance denial for something the over-the-counter version could solve today?
Quick answer: If you were just diagnosed with type 2 diabetes and are not on insulin, there is a real chance your insurance will not cover a prescription CGM at all, regardless of how badly you want one. This is not a reason to panic; it is the reason over-the-counter CGMs like Stelo exist. This guide walks through the actual decision, not just the feature comparison.
The Question Everyone Skips: Will Insurance Even Cover One?
Most CGM comparison content jumps straight to accuracy, sensor life, and app features. For a newly diagnosed type 2 diabetic, that is often the wrong starting point, because a real percentage of you will not qualify for prescription CGM coverage in the first place, no matter which brand you prefer.
Medicare’s own coverage criteria for a prescription CGM require that you meet at least one of the following:
- You are treated with insulin (any type, any amount), or
- You have documented problematic hypoglycemia, or
- You have stage 3, 4, or 5 chronic kidney disease, or
- You are pregnant with diagnosed diabetes
If you were just diagnosed with type 2 diabetes and your doctor started you on lifestyle changes, metformin, or another non-insulin medication, you likely do not meet any of these criteria yet. Many commercial insurers use similar prior-authorization logic to Medicare’s, though not identically, so this same gap often applies whether you are on Medicare or a private plan. That means the prescription CGM you have been reading about, the one with real-time alarms and the most accurate sensor, may simply not be available to you through insurance right now, regardless of how well-managed or poorly-managed your diabetes is.
This is exactly the gap the over-the-counter CGM category was built to fill.
The Four Real Options, and Who Each One Is Actually For
| Device | Access | Built For | Real-Time Alarms |
|---|---|---|---|
| Dexcom G7 | Prescription | Type 1 or Type 2, especially on insulin | Yes |
| Freestyle Libre 3 | Prescription | Type 1 or Type 2, especially on insulin | Yes |
| Dexcom Stelo | Over-the-counter | Type 2, not on insulin, not prone to lows | No |
| Abbott Lingo | Over-the-counter | General wellness, not cleared for diabetes management | No |
Notice that Lingo is not actually cleared for diabetes management at all; it is positioned as a general wellness product. If you have an actual type 2 diabetes diagnosis, Stelo, not Lingo, is the OTC option built for your situation specifically.
The Real Decision Tree
Start here: Are you on insulin, or do you have documented low blood sugar episodes?
If yes: you likely qualify for prescription coverage. Ask your doctor about Dexcom G7 or Freestyle Libre 3, both of which include real-time high and low alerts, an important safety feature if you are at genuine risk of hypoglycemia.
If no (you are newly diagnosed, not on insulin, managing with lifestyle changes and metformin): you may not qualify for insurance-covered prescription CGM yet. You have three realistic paths:
- Ask your doctor to prescribe one anyway and pay out of pocket if denied. Some doctors will still write the prescription; you would just be paying retail price without insurance covering it, which can run significantly higher than the OTC monthly cost.
- Go over-the-counter with Stelo. Built specifically for your situation: type 2, non-insulin, not prone to dangerous lows. No prescription hurdle, no prior authorization fight.
- Start with a cheaper option first. A standard blood glucose meter with test strips, used a few times a day around meals, costs a fraction of any CGM and can still show you meaningful patterns while you and your doctor figure out the bigger picture.
What You Give Up Going the OTC Route
Be clear-eyed about the tradeoff. Stelo and Lingo both use similar underlying sensor technology to their prescription siblings, but with real feature differences:
- No real-time high/low alarms. If you are not at meaningful risk of dangerous lows, this matters less. If you are unsure, ask your doctor directly rather than assuming.
- Slower data updates, roughly every 15 minutes on OTC devices versus every 1 to 5 minutes on prescription models.
- No caregiver-sharing features in most OTC apps, which matters if you want a family member to see your readings remotely.
- Slightly shorter or different sensor wear time depending on the specific device.
None of these are dealbreakers for someone newly diagnosed and specifically trying to learn how food, activity, and sleep affect their glucose day to day, which is a different job than managing insulin dosing safely.
The Cost Comparison, Realistically
A prescription CGM with good insurance coverage can be genuinely inexpensive, sometimes cheaper than the OTC options once a copay applies. Without insurance covering it, prescription CGMs can run $75 to $150 or more per sensor depending on the model and pharmacy. Stelo runs on a subscription model, commonly cited around $89 for a 30-day, two-sensor supply. The honest math: if you can get prescription coverage, it is often the better value. If you cannot, Stelo is usually cheaper than paying full retail for a prescription CGM out of pocket.
A Realistic Starting Plan
- Ask your doctor directly: whether, based on your current treatment, insurance would likely cover a CGM, or whether you are better off starting with an over-the-counter option. This single question saves weeks of guessing.
- If you are a Stelo candidate, start there. Low commitment, no prior authorization process, and it is specifically built for exactly your situation.
- Track your first 2 to 4 weeks of data deliberately, not just passively. Our Post-Meal Glucose Experiment Tracker is built for comparing how specific meals affect you, which is exactly what early CGM data is most useful for.
- Revisit the prescription question at your next follow-up, especially if your treatment plan changes to include insulin or if you experience any low blood sugar episodes, either of which could open up prescription coverage.
Frequently Asked Questions
Can I get a prescription CGM if I just ask my doctor?
Your doctor can write a prescription, but whether insurance covers it depends on meeting your specific plan’s medical necessity criteria, which for many non-insulin type 2 patients is not met at diagnosis. A written prescription and insurance coverage are two different things.
Is Stelo as accurate as Dexcom G7?
Stelo uses similar underlying Dexcom sensor technology to the G7, with software feature differences, including no real-time alarms and slower update frequency, rather than a fundamentally different sensor. For someone not requiring alarm-based safety monitoring, this is a reasonable trade for the accessibility.
Will my insurance situation change as my diabetes progresses?
Potentially. If your treatment plan changes to include insulin, or if you develop documented hypoglycemia or kidney complications, you may newly qualify for prescription coverage criteria you did not meet at diagnosis. This is worth revisiting at follow-up appointments, not assuming is permanently settled.
Should I just buy a prescription CGM without insurance?
That is a cost-benefit decision specific to your finances and how much the real-time alarm feature matters for your safety. For many newly diagnosed, non-insulin patients, the OTC option delivers similar day-to-day learning value at a lower out-of-pocket cost.
The Metabolic Clarity Takeaway
Which CGM is best is the wrong first question if you are newly diagnosed and not on insulin. Which CGM can you actually get, and does that gap matter for your safety, is the real question, and it has a genuinely different answer depending on your specific treatment plan. Start with that conversation, not a spec sheet.
For the full technical comparison once you have settled the access question, see our guides to Stelo vs. Lingo and Freestyle Libre 3 vs. Dexcom G7.
Sources
- Centers for Medicare and Medicaid Services, Local Coverage Determination: Glucose Monitors (L33822)
- American Diabetes Association, FAQs on CGM Coverage Criteria Changes in Medicare
- CMS, Glucose Monitoring Supplies coverage guidance
Leave a Reply